Send the following on WhatsApp
Continue to ChatRomiplostim's Effect to Optimize SVR with Telaprevir, Ribavirin, And Peg Interferon-alfa 2a in Thrombocytopenic Cirrhotics with Chronic Hepatitis C. A Placebo Controlled Prospective Clinical Trial: RESTRAINT C Trial https://www.sages.org/meetings/annual-meeting/abstracts-archive/romiplostims-effect-to-optimize-svr-with-telaprevir-ribavirin-and-peg-interferon-alfa-2a-in-thrombocytopenic-cirrhotics-with-chronic-hepatitis-c-a-placebo-controlled-prospective-clinical-trial/